R.S. Drugs And Medicals Private Limited - Company Profile

It is a pharma private limited company based in Perambur Purasawalkam, Tamil Nadu, India, established in 2017.
2017 Perambur Purasawalkam, Tamil Nadu, India Active
Last Updated:
Access Report
About R.S. Drugs And Medicals Private Limited

R.S. Drugs And Medicals Private Limited, a active private limited company, was established on 19 April 2017 in Perambur Purasawalkam, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909TN2017PTC116117. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹6.00 M.

It upholds a compliant status. Employing 27 professional, Its leadership includes Mahalingam Sathish (Director), Jayaseelan Pichamuthu (Director), Shivanandhini Jayaseelan (Director). Past directors included Mahalingam Sathish, Jayaseelan Pichamuthu, Geetha. It holds ₹8.00 Cr open charges and ₹7.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at New No.32, Old No.17 State Bank Colony, 2Nd Street, Jamaliya Nagar, Jamaliya, Perambur Purasawalkam, Tamil Nadu, 600012.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909TN2017PTC116117

  • Registration Number

    116117

  • Incorporation Date

    19 April 2017

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹6.00 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 6.00 M
  • Company Age 8 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 8.00 Cr
  • Satisfied Charges ₹ 7.00 Cr
  • Revenue Growth **** 15.85%
  • Profit Growth **** 27.32%
  • Ebitda **** 19.08%
  • Net Worth 25.47%
  • Total Assets **** 24.49%
Company report

R.S. Drugs And Medicals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into R.S. Drugs And Medicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at R.S. Drugs And Medicals Private Limited?
Current Directors
Name Designation Appointment Date Status
Mahalingam Sathish Director 01 Jun 2017 Current
Jayaseelan Pichamuthu Director 01 Jun 2017 Current
Shivanandhini Jayaseelan Director 19 Feb 2018 Current
Vijaya Bharathi Director 19 Feb 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2025 Past
Pramod Abcsdd Additional Director 29 Sep 2025 Past
Pramod Abcsdd Director 06 Oct 2017 Past
Pramod Abcsdd Director 06 Oct 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of R.S. Drugs And Medicals.

R.S. Drugs And Medicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.85% increase. The company also saw a substantial improvement in profitability, with a 27.32% increase in profit. The company's net worth Soared by an impressive increase of 25.47%.

R.S. Drugs And Medicals revenue growth over time
R.S. Drugs And Medicals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 15.85%
*******
*******
*******
*******
Revenue from Operations
*******
 15.78%
*******
*******
*******
*******
Total Assets
*******
 24.49%
*******
*******
*******
*******
Profit or Loss
*******
 27.32%
*******
*******
*******
*******
Net Worth
*******
 25.47%
*******
*******
*******
*******
EBITDA
*******
 19.08%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of R.S. Drugs And Medicals?

In 2022, R.S. Drugs And Medicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹80,000,000.00

Satisfied Charges

₹70,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 8.00 Cr
Latest Charge Details
Date Lender Amount Status
09 Apr 2018 Others ₹8.00 Cr Open
24 Jul 2017 Axis Bank Limited ₹7.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at R.S. Drugs And Medicals?

R.S. Drugs And Medicals has a workforce of 27 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of R.S. Drugs And Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R.S. Drugs And Medicals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on R.S. Drugs And Medicals
Recent Activity within the Organization
  • Annual General Meeting

    R.S. Drugs And Medicals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    R.S. Drugs And Medicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was recorded as a recent event.

  • Charges

    A charge registered on 24 Jul 2017 via Charge ID 100116991 with Axis Bank Limited was fully satisfied on 18 Jan 2019. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 8.00 Cr with Charge ID 100233746 was registered on 09 Apr 2018. was documented.

  • Director Appointment

    Shivanandhini Jayaseelan was appointed as a Director was appointed as a Director on 19 Feb 2018 & has been associated with this company since 8 years 1 month . was recorded as a recent event.

  • Director Appointment

    The activity Vijaya Bharathi was appointed as a Director was appointed as a Director on 19 Feb 2018 & has been associated with this company since 8 years 1 month . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of R.S. Drugs And Medicals Private Limited?

The CIN of R.S. Drugs And Medicals Private Limited is U51909TN2017PTC116117.

Where is R.S. Drugs And Medicals Private Limited headquartered?

R.S. Drugs And Medicals Private Limited is headquartered at New No.32, Old No.17 State Bank Colony, 2Nd Street, Jamaliya Nagar, Jamaliya, Perambur Purasawalkam, Tamil Nadu, 600012.

When was R.S. Drugs And Medicals Private Limited incorporated?

R.S. Drugs And Medicals Private Limited was incorporated on 19 April 2017.

Who are the current directors of R.S. Drugs And Medicals Private Limited?

The current directors of R.S. Drugs And Medicals Private Limited are

What is the primary industry of R.S. Drugs And Medicals Private Limited?

The primary industry of R.S. Drugs And Medicals Private Limited is Trade.

Is R.S. Drugs And Medicals Private Limited a listed company?

R.S. Drugs And Medicals Private Limited is unlisted.

What is the capital structure of R.S. Drugs And Medicals Private Limited?

The authorized capital of R.S. Drugs And Medicals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹6.00 M.

What is the compliance status of R.S. Drugs And Medicals Private Limited?

The compliance status of R.S. Drugs And Medicals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available